Skip to main content
HHS Author Manuscripts logoLink to HHS Author Manuscripts
. Author manuscript; available in PMC: 2018 Feb 22.
Published in final edited form as: Vaccine. 2013 Dec 3;32(5):572–578. doi: 10.1016/j.vaccine.2013.11.077

Tetanus, diphtheria and acellular pertussis (Tdap) vaccination among healthcare personnel–United States, 2011

Peng-jun Lu 1, Samuel B Graitcer 1, Alissa O’Halloran 1, Jennifer L Liang 2
PMCID: PMC5822443  NIHMSID: NIHMS942638  PMID: 24308960

Abstract

Background

Health-care personnel (HCP) are at risk for exposure to and possible transmission of vaccine-preventable diseases. Receiving recommended vaccines is an essential prevention practice for HCP to protect themselves and their patients. The tetanus, diphtheria and acellular pertussis vaccine (Tdap) was recommended by the Advisory Committee on Immunization Practices (ACIP) for HCP in 2006 for protection against pertussis. We assessed the recent compliance of U.S. HCP in receiving Tdap vaccination.

Methods

To estimate Tdap vaccination coverage among HCP, we analyzed data from the 2011 National Health Interview Survey (NHIS). Multivariable logistic regression and predictive marginal models were performed to identify factors independently associated with vaccination among HCP.

Results

Overall, Tdap vaccination coverage was 26.9% among HCP aged 18-64 years (95% confidence interval (CI)=24.3%, 29.7%), which was significantly higher compared with non-HCP among the same age group (11.1%; 10.5%–11.8%). Overall, vaccination coverage was significantly higher among physicians (41.5%) compared with nurses (36.5%) and other types of HCP (range 11.7% to 29.9%). Vaccination coverage was significantly higher among HCP aged 18-49 years compared with those 50-64 years (30.0% vs. 19.2%, respectively). Characteristics independently associated with an increased likelihood of Tdap vaccination among HCP were: younger age, higher education, living in the western United States, being hospitalized within past year, having a place for routine health care in clinic or health center, and receipt of influenza vaccination in the previous year. Marital status of widowed, divorced, or separated was independently associated with a decreased likelihood of Tdap vaccination among HCP.

Conclusions

By 2011, Tdap vaccination coverage was only 26.9% among HCP. Vaccination coverage varied widely by types of HCP and demographic characteristics. Emphasizing the benefits of HCP vaccination for staff and patients, providing vaccinations in the workplace and other non-traditional settings, and providing Tdap at no charge may help increase Tdap vaccination among HCP in all health-care settings.

Keywords: Tetanus, diphtheria and acellular pertussis vaccine (Tdap), vaccination, coverage, health-care personnel

Introduction

Healthcare personnel (HCP) may work (paid or unpaid) in settings with potential for exposure to patients and/or to infectious materials. HCP with such exposures include physicians, nurses, nursing assistants, therapists, technicians, emergency medical service personnel, dental personnel, pharmacists, laboratory personnel, autopsy personnel, students and trainees, and persons not directly involved in patient care but potentially exposed to infectious agents that can be transmitted to and from HCP and patients.12 HCP are at increased risk for acquiring pertussis infection as a result of contact with infected patients and waning protection from either childhood pertussis vaccination or prior pertussis infection.25 Healthcare-associated outbreaks of pertussis have been reported in healthcare facilities.68 About 8.5%–23% of HCP were infected with pertussis during these outbreaks.68 Infected HCP can serve as sources of infection for susceptible contacts, including patients, other HCP, and family members.916

Vaccination offers the best protection against pertussis infection in HCP and in adults, in general.1016 In 2006, the Advisory Committee on Immunization Practices (ACIP) recommended that HCP aged 19–64 years receive a single dose of the tetanus, diphtheria, and acellular pertussis vaccine (Tdap) to reduce the risk of transmission of pertussis in healthcare institutions.15 In 2010, ACIP updated HCP recommendations indicating that all HCP regardless of age should receive a single dose of Tdap as soon as feasible if they have not previously received Tdap.2 Vaccinating HCP with Tdap can be a cost-effective strategy to prevent outbreaks in healthcare setting.1115

We used data from the 2011 National Health Interview Survey (NHIS) to assess Tdap vaccination and identify factors independently associated with vaccination among HCP in the United States.

Methods

We analyzed data from the 2011 National Health Interview Survey (NHIS) to assess Tdap vaccination among HCP. The NHIS is an annual household survey for the U.S. non-institutionalized, civilian population conducted by the National Center for Health Statistics of the Centers for Disease Control and Prevention.17 Estimates were weighted to the adult civilian population of the United States. Face to face interviews were conducted each week throughout the year in a probability sample of households. In the sample adult core, one adult per sampled family was randomly selected and asked to complete the sample adult questionnaire. The study sample consisted of 25,823 adults aged 18-64 years. In 2011, the final response rate for the sample adult core was 66.3%.17

To determine Tdap vaccination status, respondents were asked “Have you received a tetanus shot in the past 10 years?” Respondents who answered “yes” were asked “Was your most recent tetanus shot given in 2005 or later?” An affirmative answer to this question prompted another question “Did the doctor tell you the vaccine included the pertussis or whooping cough vaccine?” Respondents without “yes” or “no” responses for the above three questions were excluded from the assessment of Tdap vaccination. Sensitivity calculations were conducted to assess the magnitude of potential bias, assuming all excluded respondents were either 1) not vaccinated or 2) vaccinated.

Healthcare personnel were defined as persons who answered “yes” to the following question: “Do you currently volunteer or work in a hospital, medical clinic, doctor’s office, dentist’s office, nursing home or some other health-care facility? This includes part-time and unpaid work in a health care facility as well as professional nursing care provided in the home”. The following question was asked regarding direct patient care: “Do you provide direct patient care as part of your routine work?” For this analysis, HCP included those reporting they did or did not provide direct patient care.

Among 2,455 HCP 18-64 years, Tdap vaccination status could be assessed for 1,769 respondents. Excluded were HCP without a “yes” or no” classification for tetanus vaccination status within the preceding 10 years (n=60 [2.4%]) and HCP without a tetanus vaccination status during 2005-2011 (n=86 [3.5%]) or those reported tetanus vaccination during 2005-2011 but were not told vaccine type by the provider (n=468 [19.0%] or did not know vaccine type (Td, or Tdap) (n=72 [2.9%]). Among 23,368 non-HCP 18-64 years, Tdap vaccination status could be assessed for 15,893 respondents. Excluded were non-HCP without a “yes” or no” classification for tetanus vaccination status within the preceding 10 years (n=807 [3.5%]), for tetanus vaccination status during 2005-2011 (n=732 [3.1%]), or those who reported tetanus vaccination during 2005-2011, but were not told vaccine type by the provider (n=5117 [21.9%]) or did not know vaccine type (Td, or Tdap) (n=820 [3.5%]).

We used SUDAAN statistical software (Research Triangle Institute, Research Triangle Park, NC) to calculate point estimates and 95% confidence intervals (CIs) of vaccination coverage.18 HCP who reported a tetanus vaccination during 2005-2011, but were unable to say whether Td or Tdap was used, were excluded from the analysis. All analyses were weighted to reflect the age, sex, and race/ethnicity of the U.S. non-institutionalized, civilian population. Bi-variable analysis was conducted using a Pearson’s χ2 to test population distributions between HCP and non HCP. We used t-tests to test the difference in vaccination coverage by HCP status and within each demographic and other characteristic category. Statistical significance was defined as p<0.05. The adjusted risk ratio or prevalence ratio, based on the predictive marginal under multivariable logistic regression model, was used to identify factors independently associated with vaccination among HCP. The risk ratio or prevalence ratio is a direct measure of effect when outcomes are not rare. Separate full multivariable logistic regression models for HCP and non-HCP were used to determine adjusted prevalence ratio of Tdap vaccination by selected demographic and access to care variables. Multivariable logistic regression models were conducted both ways (with influenza vaccination status in the model and without influenza vaccination status in the model) to check whether influenza vaccination status could change the outcome of the model.

Sensitivity analyses were conducted to evaluate the magnitude of potential recall bias for Tdap on the vaccination coverage estimate and factors associated with vaccination.

Results

Of the 25,823 adults, 9.3% (2,455) were HCP. Demographic characteristics of the study population are given in Table 1. The majority of HCP were 18-49 years (70.7%), female (71.8%), white (68.4%), married (56.2%), had a college education or higher (79.1%), were living at or above poverty (92.0%), had a place for routine health care (92.3%), and had health insurance (86.4%). Except for age group and hospitalization status, HCP differed significantly from non-HCP for all other characteristics.

TABLE 1.

Sample characteristics of participants 18–64 years in the United States, by healthcare personnel status, demographic and access-to-care variables–National Health Interview Survey (NHIS), 2011

Healthcare personnel Non healthcare personnel

Characteristic Sample Weighted % Sample Weighted %
Total 2,455 9.3 23,368 90.7
Age
18-49 1,736 70.7 16,017 69.0
50-64 719 30.3 7,351 31.0
Sex
Male 629 28.2 11,262 51.5*
Female 1,826 71.8 12,106 48.5
Race/ethnicity
Non-hispanic White 1,465 68.4 13,007 65.0*
Non-hispanic Black 434 14.4 3,502 11.8
Hispanic 319 9.6 4,783 16.1
Asian 186 5.5 1,514 4.9
Other 51 2.1 562 2.2
Marital status
Married 1,121 56.2 10,334 52.5*
Widowed/divorced/separated 498 13.8 4,658 13.4
Never married 830 30.0 8,326 34.1
Education
High school or less 509 20.9 9,543 40.3*
Some college or college graduate 1,542 63.1 11,601 50.5
Above college graduate 401 16.0 2,121 9.2
Poverty level
At or above poverty 1,995 92.0 16,841 84.1*
Below poverty 245 8.0 4,501 15.9
Region
Northeast 426 19.5 3,585 17.4*
Midwest 660 27.3 5,090 22.9
South 838 33.5 8,436 35.8
West 531 19.7 6,257 23.9
US Born
Yes 2,034 84.1 18,304 81.8*
No 421 15.9 5,052 18.2
Living with an infant aged<1 year
Yes 66 2.8 955 4.4*
No 2,391 97.2 22,441 95.6
Physician contacts within past year
None 362 13.3 5,444 22.5*
1 443 18.3 4,238 18.7
2-3 730 31.0 5,793 25.5
4-9 607 25.4 5,902 21.3
≥10 308 12.0 2,931 12.0
Hospitalization within past year
Yes 181 7.2 1,929 7.8
No 2,273 92.8 21,432 92.2
Usual place for health care
Clinic or health center 534 18.6 5,475 20.7*
Doctor’s office or HMO 1,612 70.3 13,391 61.9
Some other place 86 3.4 932 3.6
None 208 7.7 3,469 13.8
Health insurance
Yes 2,095 86.4 17,799 78.5*
No 351 13.6 5,486 21.5
Influenza vaccination
Yes 1,374 55.2 6,602 29.5*
No 1,080 44.8 16,540 70.5
*

Significant difference between healthcare personnel and non healthcare personnel (by chi-square test, p<0.05).

Health maintenance organization.

Among those for whom vaccination status could be identified, Tdap vaccination coverage among HCP was 26.9% (95% confidence interval (CI)=24.3%, 29.7%), significantly higher than among non-HCP (11.1%) (Table 2). Tdap vaccination coverage was significantly higher among HCP compared with coverage among non-HCP across all subgroups except those reporting other race or ethnicity (Table 2). Tdap vaccination coverage was 29.6% (26.3%, 33.2%) among HCP with direct patient contact, which was significantly higher compared to HCP without direct patient contact (21.8%; 17.7%, 26.5%)

TABLE 2.

Tdap vaccination coverage by healthcare personnel status, demographic and access-to-care variables among persons 18-64 years in the United States, NHIS 2011

Healthcare personnel Non healthcare personnel

Characteristic % (95% CI) % (95% CI) p-Value*
Total 26.9 (24.3-29.7) 11.1 (10.5-11.8) <0.001
Age
18-49 30.0 (26.8-33.5) 12.3 (11.4-13.2) <0.001
50-64 19.2 (15.4-23.7) 8.5 (7.7-9.5) <0.001
Sex
Male 26.4 (21.2-32.4) 9.9 (9.0-10.8) <0.001
Female 27.1 (24.2-30.2) 12.4 (11.5-13.4) <0.001
Race/ethnicity
Non-hispanic White 27.4 (24.2-30.8) 12.5 (11.6-13.4) <0.001
Non-hispanic Black 22.1 (16.8-28.5) 10.0 (8.5-11.6) <0.001
Hispanic 29.8 (22.5-38.3) 6.4 (5.4-7.6) <0.001
Asian 27.6 (19.0-38.2) 9.6 (7.6-12.1) <0.001
Other 31.2 (16.9-50.4) 18.4 (13.7-24.4) 0.155
Marital Status
Married 28.9 (25.4-32.6) 11.2 (10.3-12.1) <0.001
Widowed/divorced/separated 16.9 (12.4-22.6) 8.6 (7.3-10.1) 0.001
Never married 27.9 (23.4-32.9) 12.1 (10.9-13.3) <0.001
Education
High school or less 16.3 (11.8-22.2) 8.3 (7.4-9.3) 0.003
Some college or college graduate 28.3 (25.1-31.7) 12.8 (11.8-13.7) <0.001
Above college graduate 34.3 (27.9-41.3) 15.1 (13.0-17.4) <0.001
Poverty level
At or above poverty 27.7 (24.9-30.7) 11.6 (10.9-12.5) <0.001
Below poverty 20.0 (13.6-28.3) 10.1 (8.7-11.6) 0.001
Region
Northeast 21.8 (16.6-28.1) 9.7 (8.2-11.6) <0.001
Midwest 25.2 (20.7-30.2) 12.1 (10.6-13.7) <0.001
South 26.2 (22.2-30.7) 10.0 (8.9-11.3) <0.001
West 35.4 (28.4-43.1) 12.9 (11.6-14.2) <0.001
US Born
Yes 27.5 (24.6-30.6) 12.3 (11.5-13.1) <0.001
No 23.6 (18.3-29.9) 6.4 (5.4-7.6) <0.001
Living with an infant aged<1 year
Yes 31.8 (18.6-48.8) 20.6 (17.0-24.8) 0.167
No 26.7 (24.0-29.6) 10.7 (10.1-11.4) <0.001
Physician contacts within past year
None 14.9 (10.4-20.7) 6.3 (5.4-7.5) 0.002
1 25.2 (20.0-31.4) 9.5 (8.3-11.0) <0.001
2-3 30.0 (25.6-34.8) 11.9 (10.7-13.1) <0.001
4-9 28.8 (23.6-34.7) 14.4 (12.9-16.1) <0.001
≥10 31.6 (24.6-39.7) 16.9 (14.7-19.5) <0.001
Hospitalization within past year
Yes 39.0 (29.3-49.6) 17.7 (14.8-20.9) <0.001
No 26.0 (23.3-29.0) 10.6 (9.9-11.3) <0.001
Usual place for health care
Clinic or health center 33.1 (27.1-39.8) 12.6 (11.3-14.2) <0.001
Doctor’s office or HMO§ 27.0 (24.0-30.2) 12.1 (11.2-13.1) <0.001
Some other place 30.4 (17.4-47.5) 8.9 (6.6-12.0) 0.008
None 13.5 (8.9-20.1) 5.6 (4.5-6.9) 0.006
Health insurance
Yes 28.1 (25.3-31.2) 12.4 (11.6-13.2) <0.001
No 18.7 (13.4-25.4) 6.9 (5.9-8.1) <0.001
Influenza vaccination, past year
Yes 34.4 (30.8-38.2) 18.5 (17.0-20.2) <0.001
No 17.7 (14.5-21.4) 8.3 (7.7-9.0) <0.001
*

p value by t test for comparisons between healthcare personnel and non-healthcare personnel within each level of each characteristic.

p<0.05 by t test for comparisons within each variable with the indicated reference level.

Reference level.

§

Health maintenance organization.

In bi-variable analysis, Tdap vaccination coverage was significantly higher among HCP 18-49 years (30.0%) compared to HCP 50-64 years (19.2%) (Table 2). Tdap vaccination coverage among HCP was significantly higher among persons who reported having higher education, living at or above poverty level, living in the western United States, having greater number of physician contacts in the past year, hospitalized within past year, having a clinic/health center or doctor’s office/HMO as the usual place for health care, having health insurance, and having received influenza vaccination in the previous year (Table 2). Tdap vaccination coverage among HCP was significantly lower among persons who reported being widowed, divorced, or separated (Table 2).

In multivariable analysis, characteristics independently associated with an increased likelihood of Tdap among HCP were: younger age, higher education, living in the western United States, having been hospitalized within past year, having a clinic or health center as the usual place for health care, and receipt of influenza vaccination in the previous year (Table 3). Model results did not change whether influenza vaccination was included or not (data not shown in the Table). Marital status of widowed, divorced, or separated was independently associated with a decreased likelihood of Tdap vaccination among HCP. Characteristics independently associated with an increased likelihood of Tdap among non-HCP were: younger age, never married, higher education, living in the western United States, born in the United States, living with an infant aged<1 year, having greater number of physician contacts in the past year, having a clinic or health center or a doctor’s office/Health Maintenance Organization (HMO) as the usual place for health care, and receipt of influenza vaccination in the previous year (Table 3).

TABLE 3.

Multivariable logistic regression analysis of persons 18-64 years who reported received Tdap vaccination, by healthcare personnel status, demographic and access-to-care variables, United States, NHIS 2011

Healthcare personnel Non healthcare personnel

Characteristic Prevalence Ratio (PR)
(adjusted)
(95% CI)
p-Value* Prevalence Ratio (PR)
(adjusted)
(95% CI)
p-Value*
Age
18-49 1.6 (1.3-2.1) <0.001 1.6 (1.4-1.8) <0.001
50-64 Referent Referent
Sex
Male Referent Referent
Female 1.0 (0.8-1.3) 0.955 1.1 (1.0-1.2) 0.321
Race/ethnicity
Non-hispanic White Referent Referent
Non-hispanic Black 1.0 (0.7-1.3) 0.926 0.9 (0.7-1.0) 0.105
Hispanic 1.1 (0.8-1.5) 0.462 0.6 (0.5-0.8) <0.001
Asian 1.0 (0.7-1.5) 0.970 1.0 (0.7-1.3) 0.785
Other 1.0 (0.6-1.8) 0.944 1.5 (1.1-2.0) 0.025
Marital Status
Married Referent Referent
Widowed/divorced/separated 0.7 (0.5-0.9) 0.009 0.9 (0.7-1.1) 0.189
Never married 1.0 (0.8-1.2) 0.992 1.2 (1.0-1.3) 0.015
Education
High school or less Referent Referent
Some college or college graduate 1.7 (1.2-2.3) 0.002 1.2 (1.1-1.4) 0.005
Above college graduate 2.0 (1.4-2.8) <0.001 1.4 (1.1-1.7) 0.001
Poverty level
At or above poverty 1.1 (0.8-1.6) 0.503 1.0 (0.8-1.2) 0.793
Below poverty Referent Referent
Region
Northeast Referent Referent
Midwest 1.0 (0.7-1.3) 0.941 1.2 (0.9-1.4) 0.160
South 1.1 (0.9-1.5) 0.370 1.1 (0.9-1.3) 0.423
West 1.6 (1.2-2.2) 0.004 1.5 (1.2-1.8) <0.001
US Born
Yes 1.2 (0.9-1.7) 0.186 1.5 (1.2-1.8) <0.001
No Referent Referent
Living with an infant aged<1 year
Yes 0.9 (0.5-1.6) 0.605 1.5 (1.2-1.9) 0.001
No Referent Referent
Physician contacts within past year
None Referent Referent
1 1.2 (0.8-1.7) 0.465 1.2 (1.0-1.5) 0.091
2-3 1.3 (0.9-1.9) 0.096 1.4 (1.1-1.7) 0.002
4-9 1.3 (0.9-1.8) 0.210 1.6 (1.3-2.0) <0.001
≥10 1.2 (0.8-1.8) 0.344 1.6 (1.3-2.1) <0.001
Hospitalization within past year
Yes 1.5 (1.0-2.0) 0.045 1.1 (0.9-1.4) 0.392
No Referent Referent
Usual place for health care
Clinic or health center 1.8 (1.2-2.8) 0.004 1.5 (1.2-1.9) 0.001
Doctor’s office or HMO 1.5 (1.0-2.2) 0.062 1.3 (1.0-1.6) 0.040
Some other place 1.7 (0.9-3.4) 0.121 1.4 (1.0-2.0) 0.051
None Referent Referent
Health insurance
Yes 1.1 (0.8-1.6) 0.509 1.1 (0.9-1.3) 0.192
No Referent Referent
Influenza vaccination, past year
Yes 2.0 (1.6-2.4) <0.001 2.0 (1.8-2.2) <0.001
No Referent Referent
*

p<0.05 by t test for comparisons within each variable with the indicated reference level.

Health maintenance organization.

Tdap vaccination coverage was 41.5% (29.9%, 54.2%) for physicians, 36.5% (30.5%, 43.0%) for nurses, 29.9% (21.8%, 39.5%) for other healthcare support occupations, 27.0% (19.9%, 35.5%) for other non-physician/nurse practitioners, 25.1% (18.3%, 33.4%) for other health technologists, 13.9% (10.5%, 18.2%) for nursing, psychiatric and home health aids, and 11.7% (4.8%, 25.9%) for clinical laboratory staff (Table 4).

TABLE 4.

Tdap vaccination coverage by types of healthcare personnel and facilities among persons 18-64 years in the United States, NHIS 2011

Occupations Ambulatory health care services % (95% CI) Hospitals % (95% CI) Nursing and residential care facilities % (95% CI) Total % (95% CI)
Total 25.5 (21.6-30.0) 35.2 (29.9-40.9) 14.3 (9.7-20.5) 27.3 (24.4-30.4)
Physicians 31.4 (18.7-47.8) 58.6 (37.3-77.2) 41.5 (29.9-54.2)
Nurses 39.8 (28.7-52.0) 38.3 (30.8-46.5) 18.7 (8.2-37.0) 36.5 (30.5-43.0)
Others in non-physician/nurse practitioners group* 24.6 (16.2-35.4) 36.1 (21.1-54.4) 27.0 (19.9-35.5)
Clinical laboratory 11.7 (4.8-25.9)
Health technologists§ 23.1 (14.0-35.6) 31.8 (20.6-45.7) 12.2 (3.0-38.3) 25.1 (18.3-33.4)
Nursing, psychiatric, and home health aids 11.1 (6.8-17.8) 20.3 (12.0-32.2) 13.9 (10.5-18.2)
Healthcare support occupations 29.3 (20.2-40.5) 35.5 (18.2-57.5) 29.9 (21.8-39.5)
*

Including chiropractors, dentists, dietitians and nutritionists, optometrists, pharmacists, physician assistants, podiatrists, audiologists, occupational therapists, physical therapists, radiation therapists, respiratory therapists, etc.

Estimates are not reliable due to sample size is less than 30.

p<0.05 by t test for comparisons within each healthcare setting with physicians as the reference level.

§

Including dental hygienists, diagnostic related technologists and technicians, emergency medical technicians and paramedics, health diagnosing treating practitioner support technicians, medical records and health information technicians, opticians, dispensing, etc.

Including occupational therapist assistants and aides, physical therapist assistants, massage therapists, dental assistants, medical assistants, etc.

Depending on what proportion of excluded respondents actually received Tdap, the sensitivity analysis showed that actual Tdap coverage among HCP could fall within the range of 20.3% to 44.8%. Sensitivity analyses showed that actual Tdap coverage among non-HCP could fall within the range of 8.0% to 35.9% depending on what proportion of excluded respondents actually received Tdap. Factors associated with Tdap vaccination slightly changed when multivariable models were conducted using upper level of coverage (44.8% for HCP, 35.9% for non-HCP) as the outcome variable based on sensitivity analyses. Factors associated with Tdap vaccination did not change when multivariable models were conducted using lower level of coverage (20.3% for HCP, 8.0% for non-HCP) as the outcome variable based on sensitivity analyses.

Discussion

Healthcare personnel are recommended to receive Tdap vaccination to protect themselves, their patients, and their families.1, 2 While HCP were more likely to be vaccinated with Tdap than those who were non-HCP, even among HCP, only about 1 in 4 HCP (26.9%) reported receiving Tdap vaccination. HCP with direct patient contact reported higher coverage (29.6%) than those without direct patient care (21.8%). Vaccination coverage varied widely by types of HCP and demographic characteristics.

Reported Tdap vaccination coverage among HCP is suboptimal. Influenza and Hepatitis B (HepB) vaccines are two other vaccines recommended for HCP in the United States.2, 19, 20 Influenza vaccination coverage among HCP has ranged from 53.0% to 64.0% based on the 2011 NHIS (CDC unpublished data), the 2007 National Immunization Survey-Adult, and a 2011 HCP internet panel survey.19, 20 HepB coverage among HCP has ranged from 63% to 70% based on the 2007 National Immunization Survey-Adult, and the 2010 NHIS.20, 21 These estimates were higher compared with the 2011 estimated Tdap vaccination coverage among HCP. Influenza and HepB vaccination, however, have been recommended for HCP since 1984 and 1982, respectively, compared with Tdap which has been recommended for HCP only since 2006.15, 19, 21 Other factors, such as perceived risk and targeted vaccination campaigns, may also contribute to higher influenza and HepB vaccination among HCP.1921 Since Tdap vaccination coverage was first assessed in the United States in 2008,22 Tdap coverage among HCP has increased from 15.9% in 200820, 21 to 26.9% in 2011. Continued monitoring of Tdap vaccination among HCP is useful for evaluating vaccination campaigns, for planning, and to control pertussis among HCP and their contacts.

Suboptimal Tdap coverage may in part be due to lower awareness of Tdap vaccine. One study showed that only 19% of individuals in the general population and about 39% of HCP reported having ever heard of Tdap vaccine.23 Additionally, the intent to receive Tdap vaccination is also low among HCP. One study indicated that only 13% of the respondents reported they planned to receive the vaccine.24 Intent to receive Tdap was low among all HCP occupational groups, including physicians (22%), nurses (9%), nursing aides (18%), therapists (14%), persons with other occupations (14%), technicians and persons with other healthcare support occupations (12%), and nurse practitioners and physician assistants (11%).24 Additional education of HCP about the benefits of vaccination might help increase vaccination coverage. Confusion about the interval to receive Tdap after receipt of the last Td vaccination might also have affected Tdap uptake among HCP. Not all HCP were instructed to get Tdap on a shortened interval: the 2006 ACIP recommendation stated that HCP who have direct patient contact should receive a single dose of Tdap as soon as feasible, with an interval as short as 2 years from the last dose of Td. HCP without direct patient contact were recommended to receive a single dose of Tdap to replace the next scheduled Td vaccination according to the routine recommendation at an interval no greater than 10 years since the last Td vaccination (15). ACIP recently (2011) recommended use of Tdap regardless of interval since the last tetanus- or diphtheria-toxoid containing vaccine.16

Several characteristics were associated with Tdap vaccination coverage. As seen in other studies, age, education, and marital status were associated with vaccination.20, 22, 23, 25 Reported receipt of influenza vaccination in the past year among HCP was also associated with Tdap vaccination. Receipt of influenza vaccination in the past year may be a reflection of health seeking behavior and acceptance of or access to vaccinations or preventive services in general.25 Annual influenza vaccination among HCP in work settings could provide a platform for delivering Tdap vaccine and thus may help increase Tdap vaccination coverage among HCP.

We found that Tdap vaccination coverage among HCP who reported a clinic or health center as the place they usually go to for health care or had been hospitalized in the past 12 months was significantly higher than those who did not have a place they usually go for health care or had not been hospitalized in the past 12 months, even after controlling for other demographic and access-to-care factors. Having contact with a physician plays an important role in vaccination uptake.13, 14 Routine provider contacts or hospitalization can provide important opportunities for providers to recommend and vaccinate HCP to improve Tdap vaccination coverage. However, one study showed that the most common reason given by HCP who did not plan to receive Tdap vaccine is that their provider did not recommend the vaccine to them.24 Healthcare providers should take advantage of opportunities to recommend and vaccinate their patients when they access the medical system.

Living in the western United States was independently associated with a higher Tdap vaccination coverage among HCP. This result may reflect the percentage of hospital requirements for Tdap vaccination of HCP by region. One study indicated that about 31% of U.S. hospitals required HCP to receive Tdap vaccine and this percentage varied significantly by region.26 The percentage of hospitals requiring HCP to receive Tdap vaccine was 22.5% in the Midwest, 27.8% in the Northeast, 30.1% in the South, and 47.4% in the West. The percentage of hospitals in the western United States requiring HCP to receive Tdap vaccine was significantly higher compared with other regions.26 In addition, our study indicated that vaccination coverage was higher in hospital settings, which is consistent with another study indicating that influenza vaccination coverage was higher in hospital settings as well.20

A comprehensive employer vaccination program including education about the benefits of vaccination, convenient access to vaccination services, the provision of Tdap vaccination at no charge, and vaccination requirements may help improve vaccination coverage.2, 15, 2729 Institutional requirements for influenza vaccination have led to higher vaccination levels.27 One study examined influenza vaccination coverage following institution of vaccination policies, within a sample of U.S. hospitals, and found that single season influenza vaccination rates increased approximately 15% after institution of hospital policies requiring receipt of influenza vaccination.27 Policies requiring vaccination with Tdap vaccine have also improved vaccination levels.28, 29 In 2010, the University of North Carolina made employment of HCP with direct patient contact conditional upon Tdap vaccination. After implementation of the policy, a nearly 100% compliance rate was achieved.29 Hospitals and other healthcare institutions should consider providing vaccination at no or minimal cost to their employees and should consider policies to encourage vaccination.

The findings in this report are subject to several limitations. First, vaccination coverage was self-reported and therefore might be subject to recall bias. No studies have evaluated the validity of self-reported Tdap vaccination among HCP. Self-reported influenza and pneumococcal vaccination status among adults have been shown to be fairly sensitive and specific.3033 Second, many respondents were excluded from estimations of Tdap coverage, creating a potential for bias. HCP who reported a tetanus vaccination during 2005-2011, but were unable to say whether Td or Tdap was used, were excluded. Sensitivity analyses were conducted to evaluate the magnitude of potential bias. Depending on what proportion of excluded respondents actually received Tdap, actual self-reported Tdap coverage among HCP could fall within the range of 20.3% to 44.8%. Based on our study, the percentages of respondents who reported unknown vaccine type were lower among HCP compared to non-HCP. Since vaccination is based on self-report and HCP have greater awareness of Tdap and Td differences and less likely to report unknown vaccine type, and thus might yield a higher coverage among HCP compared to non-HCP. Finally, confusion with Td and changes in ACIP recommendations since 2006 may affect the accuracy of self-reported Tdap vaccination coverage and thus future studies in terms of validity of Tdap vaccination are necessary.2, 15

Tdap vaccination among HCP is crucial to minimize risk of pertussis infection among HCP, their patients, and their families. Despite the availability of a safe and effective vaccine, Tdap vaccination coverage among HCP was low (26.9%). Comprehensive strategies are needed to further improve uptake of Tdap vaccination coverage for HCP. Recommended approaches include: emphasizing the benefits of HCP vaccination for staff and patients; considering the level of vaccination coverage among HCP to be one measure of patient safety and quality assurance; electronic tracking of coverage levels by ward, unit, and occupation; providing vaccinations in the workplace and free of charges; identifying where vaccination coverage levels are low and using the information to target interventions; developing comprehensive health care workplace infectious control programs that include pertussis control and address Tdap vaccination of HCP; and implementing catch-up vaccination programs for HCP who are already employed and ensuring that newly hired HCP receive necessary vaccinations.2, 3436 Any comprehensive strategy needs to be tailored to the needs of the health care institution to improve coverage and protect HCP, their patients, and their families.

Acknowledgments

We thank James A. Singleton, Stacie M. Greby, and Walter W. William for their thoughtful review of the manuscript.

Footnotes

Disclaimer: The findings and conclusions in this paper are those of the authors and do not necessarily represent the views of CDC.

Conflict of Interest Statement:

All authors have no conflicts of interest to be stated.

References

  • 1.US Department of Health and Human Services. Definition of health-care personnel (HCP) Available at: http://www.hhs.gov/nvpo/nvac/influenza_subgroup_final_report.pdf. Accessed August 1, 2012.
  • 2.Centers for Disease Control and Prevention (CDC) Immunization of health-care personnel: Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR. 2011;60(RR-07):1–45. [PubMed] [Google Scholar]
  • 3.Wright SW, Decker MD, Edwards KM. Incidence of pertussis infection in healthcare workers. Infect Control Hosp Epidemiol. 1999;20:120–123. doi: 10.1086/501593. [DOI] [PubMed] [Google Scholar]
  • 4.De Serres G, Shadmani R, Duval B, Boulianne N, Déry P, Douville Fradet M, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis. 2000;182:174–179. doi: 10.1086/315648. [DOI] [PubMed] [Google Scholar]
  • 5.Deville JG, Cherry JD, Christenson PD, Pineda E, Leach CT, Kuhls TL, et al. Frequency of unrecognized bordetella pertussis infections in adults. Clin Infect Dis. 1995;21:639–642. doi: 10.1093/clinids/21.3.639. [DOI] [PubMed] [Google Scholar]
  • 6.Centers for Disease Control and Prevention (CDC) Outbreaks of pertussis associated with hospitals–Kentucky, Pennsylvania, and Oregon, 2003. MMWR. 2005;54:67–71. [PubMed] [Google Scholar]
  • 7.Pascual FB, McCall CL, McMurtray A, Payton T, Smith F, Bisgard KM. Outbreak of pertussis among healthcare workers in a hospital surgical unit. Infect Control Hosp Epidemiol. 2006 Jun;27(6):546–52. doi: 10.1086/506232. [DOI] [PubMed] [Google Scholar]
  • 8.Boulay BR, Murray CJ, Ptak J, Kirkland KB, Montero J, Talbot EA. An outbreak of pertussis in a hematology-oncology care unit: implications for adult vaccination policy. Infect Control Hosp Epidemiol. 2006;27:92–95. doi: 10.1086/500420. [DOI] [PubMed] [Google Scholar]
  • 9.Steketee RW, Wassilak SG, Adkins WN, Jr, et al. Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled. J Infect Dis. 1988;157:434–440. doi: 10.1093/infdis/157.3.434. [DOI] [PubMed] [Google Scholar]
  • 10.Ward JI, Cherry JD, Chang SJ, Partridge S, Lee H, Treanor J, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med. 2005;353:1555–1563. doi: 10.1056/NEJMoa050824. [DOI] [PubMed] [Google Scholar]
  • 11.Calugar A, Ortega-Sanchez IR, Tiwari T, Oakes L, Jahre JA, Murphy TV. Nosocomial pertussis: costs of an outbreak and benefits of vaccinating health care workers. Clin Infect Dis. 2006;42(7):981–8. doi: 10.1086/500321. [DOI] [PubMed] [Google Scholar]
  • 12.Baggett HC, Duchin JS, Shelton W, Zerr DM, Heath J, Ortega-Sanchez IR, et al. Two nosocomial pertussis outbreaks and their associated costs—King County, Washington, 2004. Infect Control Hosp Epidemiol. 2007;28(5):537–43. doi: 10.1086/513497. [DOI] [PubMed] [Google Scholar]
  • 13.Centers for Disease Control and Prevention (CDC) Hospital-acquired pertussis among newborns—Texas, 2004. MWMR. 2008;57(22):600–3. [PubMed] [Google Scholar]
  • 14.Sandora TJ, Gidengil CA, Lee GM. Pertussis vaccination for health care workers. Clin Microbiol Rev. 2008;21(3):426–34. doi: 10.1128/CMR.00003-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Centers for Disease Control and Prevention (CDC) Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine– Recommendations of the Advisory Committee on Immunization Practices (ACIP) and Recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for Use of Tdap Among Health-Care. MMWR. 2006;55(RR17):1–33. [PubMed] [Google Scholar]
  • 16.Centers for Disease Control and Prevention (CDC) Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR. 2011;60(01):13–15. [PubMed] [Google Scholar]
  • 17.Centers for Disease Control and Prevention (CDC) National Health Interview Survey. Available at: ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHIS/2011/srvydesc.pdf Accessed August 2, 2012.
  • 18.Shah B, Barnwell B, Bieier G. SUDAAN User’s Manual, Release 10.1. Research Triangle Park, NC: Research Triangle Institute; 2010. [Google Scholar]
  • 19.Lu PJ, Euler GL. Influenza, hepatitis B and tetanus vaccination coverage among health care personnel in the United States. Am J Infect Control. 2011;39:488–494. doi: 10.1016/j.ajic.2010.10.009. [DOI] [PubMed] [Google Scholar]
  • 20.Centers for Disease Control and Prevention (CDC) Influenza vaccination coverage among health-care personnel—United States, 2010-11 influenza season. MMWR. 2011;60(32):1073–1077. [PubMed] [Google Scholar]
  • 21.Centers for Disease Control and Prevention (CDC) Adult vaccination coverage, United States, 2010. MMWR. 2012;61(04):66–72. [PubMed] [Google Scholar]
  • 22.Centers for Disease Control and Prevention (CDC) Tetanus and Pertussis Vaccination Coverage Among Adults Aged ≥18 Years — United States, 1999 and 2008. MMWR. 2010;59(40):1302–1306. [PubMed] [Google Scholar]
  • 23.Miller BL, Kretsinger K, Euler GL, Lu PJ, Ahmed F. Barriers to early uptake of tetanus, diphtheria and acellular pertussis vaccine (Tdap) among adults-United States, 2005-2007. Vaccine. 2011 May 17;29(22):3850–6. doi: 10.1016/j.vaccine.2011.03.058. [DOI] [PubMed] [Google Scholar]
  • 24.Goins WP, Schaffner W, Edwards KM, Talbot TR. Healthcare workers’ knowledge and attitudes about pertussis and pertussis vaccination. Infect Control Hosp Epidemiol. 2007 Nov;28(11):1284–9. doi: 10.1086/521654. [DOI] [PubMed] [Google Scholar]
  • 25.Lu PJ, Byrd KK, Murphy TV, Weinbaum C. Hepatitis B vaccination coverage among high-risk adults 18-49 years, U.S., 2009. Vaccine. 2011;29(40):7049–7057. doi: 10.1016/j.vaccine.2011.07.030. [DOI] [PubMed] [Google Scholar]
  • 26.Miller BL, Ahmed F, Lindley MC, Wortley PM. US hospital requirements for pertussis vaccination of healthcare personnel, 2011. Infect Control Hosp Epidemiol. 2011 Dec;32(12):1209–12. doi: 10.1086/662711. [DOI] [PubMed] [Google Scholar]
  • 27.Miller BL, Ahmed F, Lindley MC, Wortley PM. Increases in vaccination coverage of healthcare personnel following institutional requirements for influenza vaccination: a national survey of U.S. hospitals. Vaccine. 2011;29(50):9398–9403. doi: 10.1016/j.vaccine.2011.09.047. [DOI] [PubMed] [Google Scholar]
  • 28.Weber DJ, Consoli SA, Sickbert-Bennett E, Rutala WA. Assessment of a mandatory tetanus, diphtheria, and pertussis vaccination requirement on vaccine uptake over time. Infect Control Hosp Epidemiol. 2012;33(1):81–83. doi: 10.1086/663337. [DOI] [PubMed] [Google Scholar]
  • 29.Lindley MC, Lorick SA, Spinner JR, Krull AR, Mootrey GT, Ahmed F, Myers R, Bednash GP, Cymet TC, Maeshiro R, Raines CF, Shannon SC, Sondheimer HM, Strikas RA. Student vaccination requirements of U.S. health professional schools: a survey. Ann Intern Med. 2001;154(6):391–400. doi: 10.7326/0003-4819-154-6-201103150-00004. [DOI] [PubMed] [Google Scholar]
  • 30.Donald RM, Baken L, Nelson A, Nichol KL. Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients. Am J Prev Med. 1999;16(3):173–177. doi: 10.1016/s0749-3797(98)00159-7. [DOI] [PubMed] [Google Scholar]
  • 31.Zimmerman RK, Raymund M, Janosky JE, Nowalk MP, Fine MJ. Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. Vaccine. 2003;21:1486–1491. doi: 10.1016/s0264-410x(02)00700-4. [DOI] [PubMed] [Google Scholar]
  • 32.Mangtani P, Shah A, Roberts JA. Validation of influenza and pneumococcal vaccine status in adults based on self-report. Epidemiol Infect. 2007 Jan;135(1):139–43. doi: 10.1017/S0950268806006479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Shenson D, DiMartino D, Bolen J, Campbell M, Lu PJ, Singleton JA. Validation of self-reported pneumococcal vaccination in behavioral risk factor surveillance surveys: experience from the sickness prevention achieved through regional collaboration (SPARC) program. Vaccine. 2005;23:1015–20. doi: 10.1016/j.vaccine.2004.07.039. [DOI] [PubMed] [Google Scholar]
  • 34.Poland GA, Shefer AM, McCauley M, Webster PS, Whitely-Williams PN, Peter G, et al. Standards for adult immunization practice. Am J Prev Med. 2003;25(2):144–150. doi: 10.1016/s0749-3797(03)00120-x. [DOI] [PubMed] [Google Scholar]
  • 35.Lindley MC, Horlick GA, Shefer AM, Shaw FE, Gorji M. Assessing state immunization requirements for healthcare workers and patients. Am J Prev Med. 2007 Jun;32(6):459–65. doi: 10.1016/j.amepre.2007.02.009. [DOI] [PubMed] [Google Scholar]
  • 36.Guide to Community Preventive Services. Available at: http://www.thecommunityguide.org/index.html. Accessed January 8, 2012.

RESOURCES